International Companies

Eli Lilly launches new Zepbound pen with month of doses

By Benjamin Chiou

Date: Monday 23 Feb 2026

(Sharecast News) - Eli Lilly & Co on Monday unveiled a new multi-dose form of its blockbuster obesity drug Zepbound, allowing patients to receive a months' worth of doses in a single pen.
Shares were up 3.6% at $1,046.06 in early deals on Wall Street, supported by the news that Novo...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page